Stay updated on COVID-AIV for Respiratory Failure Clinical Trial
Sign up to get notified when there's something new on the COVID-AIV for Respiratory Failure Clinical Trial page.

Latest updates to the COVID-AIV for Respiratory Failure Clinical Trial page
- Check3 days agoChange DetectedThe record describes a completed Phase 2/3 study of intravenous aviptadil for critical COVID-19 with respiratory failure, including its design, eligibility criteria, outcomes, and study documents.SummaryDifference58%

- Check10 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check17 days agoChange DetectedA sitewide NIH banner announces transition updates and FAQs, including NIH’s shift from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check24 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check31 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check52 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden error page. The previous study details and site navigation are replaced by the access-denied message and standard footer.SummaryDifference19%

Stay in the know with updates to COVID-AIV for Respiratory Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the COVID-AIV for Respiratory Failure Clinical Trial page.